病理特征 | BMI < 24 kg/m3 | BMI ≥24 kg/m3 | P值 | |
ER | 阴性 | 22 (17.32%) | 12 (9.45%) | 0.8389 |
阳性 | 58 (45.67%) | 35 (27.56%) | ||
PR | 阴性 | 20 (15.75%) | 13 (10.24%) | 0.8346 |
阳性 | 60 (47.24%) | 34 (26.77%) | ||
Her-(2) | 阴性 | 61 (48.03%) | 30 (26.62%) | 0.156 |
阳性 | 19 (14.96%) | 17 (13.39%) | ||
Ki-67 | <14% | 22 (17.32%) | 15 (11.81%) | 0.6867 |
≥14% | 58 (45.67%) | 32 (25.20%) | ||
淋巴结转移 | 无 | 55 (43.31%) | 30 (23.62%) | 0.6963 |
有 | 25 (19.69%) | 17 (13.39%) | ||
SBR分级 | 1 | 12 | 8 | 0.262 |
2 | 59 | 29 | ||
3 | 9 | 10 | ||
TNM分期 | I期 | 26 (20.47%) | 20 (15.75%) | 0.3391 |
II~IV期 | 54 (42.52%) | 27 (21.26%) | ||
分子类型 | LuminalA | 28 | 19 | 0.7853 |
LuminalB | 34 | 19 | ||
ERBB2+型 | 7 | 5 | ||
三阴性 | 11 | 4 | ||
是否绝经 | 是 | 49 (38.58%) | 39 (30.71%) | 0.0161 |
否 | 31 (24.41%) | 8 (6.30%) | ||
受教育程度 | 高中及以下 | 52 | 29 | 0.9275 |
本科 | 23 | 15 | ||
硕士及以上 | 5 | 3 |